Table 1.
Patients characteristics and treatments at diagnosis
| No. (%) | |
|---|---|
| Sex | |
| Female | 21 (49) |
| Male | 22 (51) |
| Median age years (range) | 51 (27–80) |
| MGMT promoter methylation status | |
| Methylated | 18 (42) |
| Unmethylated | 8 (19) |
| Unknown | 17 (39) |
| IDH mutation | |
| Present | 6 (14) |
| Absent | 20 (47) |
| Unknown | 17 (39) |
| KPS | |
| 100 | 11 (26) |
| 90 | 19 (44) |
| 80 | 2 (4) |
| 70 | 11 (26) |
| Time to Relapse from initial diagnosis | |
| ≤ 12 months | 21 (49) |
| > 12–24 months | 13 (30) |
| > 24 months | 9 (21) |
| Treatment at Initial Diagnosis | |
| Surgery | 43 (100) |
| Complete Resection (CR) | 24 (56) |
| Subtotal Resection (SR) | 5 (12) |
| Partial Resection (PR) | 12 (28) |
| Biopsy | 2 (4) |
| Radiotherapy | 43 (100) |
| CT Concomitant and adjuvant (TMZ) | 43 (100) |
MGMT methylguanine-DNA methyltransferase, IDH isocitrate dehydrogenase, KPS karnofsky performance status, TMZ Temozolomide